Status:
RECRUITING
Out of State - tAN hEDS
Lead Sponsor:
Medical University of South Carolina
Collaborating Sponsors:
MUSC Blue Sky initiative
Conditions:
Hypermobile EDS (hEDS)
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Hypermobile EDS and hypermobile spectrum disorder (collectively referred to as hEDS) are estimated to affect 1 in 500 individuals worldwide. hEDS patients have limited treatment options for their nume...
Detailed Description
The Ehlers-Danlos syndromes (EDS) are a group of heritable, connective tissue disorders characterized by joint hypermobility, skin hyperextensibility, and tissue fragility2. Hypermobile EDS (hEDS) is ...
Eligibility Criteria
Inclusion
- Ages of 18 and 65;
- Participants who meet the 2017 diagnostic criteria for hEDS or HSD4-5 with persistent symptoms in at least two of the domains to be followed during the intervention (pain, fatigue, sleep, anxiety, depression, quality of life, GI function, autonomic function and immune function)
- Mentally capable of reading, writing, giving consent, and following instructions;
Exclusion
- Mentally capable of reading, writing, giving consent, and following instructions;
- Not pregnant;
- No history of seizures;
- no prior history of trauma or damage to ear
- History of documented Autism spectrum disorder (ASD) diagnosis
- Residing in the state of South Carolina
Key Trial Info
Start Date :
November 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06548594
Start Date
November 27 2024
End Date
April 1 2026
Last Update
December 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina Institute of Psychiatry
Charleston, South Carolina, United States, 29425